CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall St falls as tech earnings spark AI spending worries and oil hits $100
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- RTX stock jumps as company lifts guidance after Q2 beat
Cytosorbents (CTSO) Tops Q3 EPS by 1c, Misses on Revenue
November 13, 2025 4:09 PM ESTCytosorbents (NASDAQ: CTSO) reported Q3 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $9.5 million versus the consensus estimate of $10.4 million.
For earnings history and earnings-related data on Cytosorbents (CTSO) click here.
... More